Data and analytics professionals in Pharmaceuticals
Oncology is the one therapy area named in these pharmaceuticals data and analytics titles, held by three people at GSK, Novartis, Pfizer and Jazz Pharmaceuticals, while the rest cover commercial AI, forecasting, data strategy and omnichannel analytics. Drug companies deciding which prescription, market access or launch data can support a forecast get views from nine companies, including MSD, Bristol Myers Squibb, Takeda and Ipsen.
Professionals to explore
Arindam Mukherjee
LinkedInExperience: Director Data Strategy & Management · Ipsen
Arindam Mukherjee is Director Data Strategy & Management at Ipsen since 2024. Arindam was Head - BI Analytics & Data Strategy at Lundbeck (2022–2024), Head Commercial Data & Analytics at Apellis Pharmaceuticals (2020–2022), North America - Life Science Commercial Lead at Accenture (2015–2020) and Consultant at ZS (2013–2015), a fit for commercial data strategy questions.
Is this you? Claim your profile and get paid for calls.
Jun Qi
LinkedInExperience: Sr. Director of Data Analytics & Insights · SpringWorks Therapeutics
Jun Qi is Sr. Director of Data Analytics & Insights at SpringWorks Therapeutics since 2024. Jun was Sr. Director of Commercial Analytics at Otsuka Pharmaceutical Companies (U.S.) (2023–2024), Director of Advanced Analytics at Regeneron (2020–2023), and Director of Reporting (2018–2020) and Forecasting and Performance Assessment Leader (2015–2018) at AstraZeneca.
Is this you? Claim your profile and get paid for calls.
Madhupriya Jha
LinkedInExperience: Executive Director, Data Analytics & Operations · Zydus Therapeutics
Madhupriya Jha holds Executive Director, Data Analytics & Operations at Zydus Therapeutics since 2026, and was Executive Director, AI and Data Analytics Lead, Commercial and Medical at Pfizer (2023–2025). At Novartis, Madhupriya held Global Service Delivery Lead, Director, Analytics, Advanced Analytics, AI ML (2017–2023) and Associate Director, Commercial Analytics Centre of Excellence (2015–2017), and names commercialization and launch.
Is this you? Claim your profile and get paid for calls.
Nadia Tantsyura
LinkedInExperience: Executive Director, Commercial AI & Advanced Analytics · Bristol Myers Squibb
Nadia Tantsyura's current title is Executive Director, Commercial AI & Advanced Analytics at Bristol Myers Squibb (since 2026). Nadia held Executive Director, Worldwide Omnichannel Excellence Insights at Bristol Myers Squibb (2025–2026), Director, Customer Engagement Orchestration at Merck (2024–2025) and Director, Market Access Analytics, Analytics & Insights at Boehringer Ingelheim (2019–2022), and describes leading omnichannel strategy at Merck.
Is this you? Claim your profile and get paid for calls.
Nagarajan D
LinkedInExperience: Former Director Commercial analytics -RLT Prostate · Novartis
Nagarajan D is a former Director Commercial analytics -RLT Prostate at Novartis (2020–2023), where Nagarajan also held Head-Integrated Insights-Oncology Franchise (2016–2019) and Team Leader, Business Analytics (2012–2016). Nagarajan is Director- Insights, Strategy and Execution (Oncology pipeline) at Pfizer since 2023, a fit for oncology pipeline and launch questions.
Is this you? Claim your profile and get paid for calls.
Prasheel Lillaney
LinkedInExperience: Director, Decision Science & AI · GSK
At GSK, Prasheel Lillaney is Director, Decision Science & AI since 2024. Prasheel was Director, Global Insights and Analytics, Early Assets at AstraZeneca (2023–2024), and at Jazz Pharmaceuticals held Customer Journey Innovation (2019–2022), Business Intelligence & Analytics (2018–2019) and Benefit Risk Management, Pharmacovigilance (2016–2018), and names RWE and commercial strategy.
Is this you? Claim your profile and get paid for calls.
Purvi Dev
LinkedInExperience: Senior Director, Commercial Forecasting and Analytics · Jazz Pharmaceuticals
Purvi Dev holds Senior Director, Commercial Forecasting and Analytics at Jazz Pharmaceuticals since 2024, with Senior Director, Global Pipeline Forecasting and Analytics, Corporate Strategy (2023–2024) and Director, Market Insights and Analytics, Oncology (2019–2023) there. Purvi was Principal at IQVIA (2017–2019) and Associate Principal, Oncology Real World Analytics Solutions at IMS Health (2014–2016).
Is this you? Claim your profile and get paid for calls.
Sopheara Peoples
LinkedInExperience: Senior Director, Head of Oncology Digital Data & Tech · GSK
Sopheara Peoples has been Senior Director, Head of Oncology Digital Data & Tech at GSK since 2024. Sopheara's other GSK titles include Director, Commercial Analytics Capability and Strategy (2022–2024), Oncology Commercial Analytics Capability and Strategy Lead (2020–2022) and Senior Manager, Commercial Analytics - US Pharma Oncology (2019–2020), a fit for oncology commercial analytics questions.
Is this you? Claim your profile and get paid for calls.
Sreenath Nampally
LinkedInExperience: Director, Data Strategy & Reporting · Takeda
Sreenath Nampally is Director, Data Strategy & Reporting at Takeda since 2024 and was Director, Commercial Data Strategy, Data Management & Visualization at Bayer (2021–2024). At AstraZeneca, Sreenath held Principal Data Scientist (2018–2021) and Associate Director, Data Management, Data Strategy and Analytics (2014–2018), and names preclinical, clinical and commercial data work.
Is this you? Claim your profile and get paid for calls.
Subhankar Biswas
LinkedInExperience: Director Commercial AI and Analytics and Market Activation · MSD
From Hyderabad, Subhankar Biswas is Director Commercial AI and Analytics and Market Activation at MSD since 2025, and held Director Data Science and Visualization (2024–2025) and Associate Director Data Visualization and Analytics (2022–2024) there. At Novartis, Subhankar held US Brand Analytics and Platform Enablement titles (2019–2022), a fit for brand analytics questions.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Forecasting questions fit Purvi Dev at Jazz Pharmaceuticals and Jun Qi, who held forecasting and reporting titles at AstraZeneca. Oncology launch questions fit Sopheara Peoples and Nagarajan D, omnichannel and market access questions fit Nadia Tantsyura, and Arindam Mukherjee and Sreenath Nampally suit commercial data strategy questions.
Questions to take into the conversation
- 01How do you forecast a launch when the comparable products had a different payer mix or line of therapy?
- 02Which specialty pharmacy and claims data is reliable enough to track patient starts and drop-off?
- 03How do you measure whether an omnichannel campaign changed prescribing rather than reaching the same physicians more often?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.